
Insulet Partners with the International Diabetes Federation Europe to Support Advocacy Activities Across the Continent
“We are delighted to partner with IDF Europe, which represents 71 national diabetes organizations in 46 countries across Europe,” said DJ Cass, General Manager, Insulet Europe. “Through its advocacy work, IDF Europe’s mission is to improve the health outcomes of its 570,000 members and we look forward to working more closely with them through this powerful collaboration starting with the Youth Leadership Camp in the Czech Republic.”
The Youth Leadership Camp is an annual event organized by IDF Europe to
provide a unique experience for young people with diabetes to learn
skills to become ambassadors for change, while sharing knowledge and
interacting with their peers from multiple countries. The 8th
edition of the IDF Europe Youth Leadership Camp is taking place in the
“There are one million people living with Type 1 Diabetes in
Insulet’s partnership with IDF Europe will also include joint activities
for World Diabetes Day on
About Insulet Corporation:
On
For more information, please visit: www.insulet.com and www.myomnipod.com.
About IDF Europe:
IDF
Forward-Looking Statement:
This press release may contain forward-looking statements concerning Insulet's expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, and other risks and uncertainties described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on February 22, 2018 in the section entitled "Risk Factors," and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180709005239/en/
Source:
Insulet Corporation
Investor Relations and Corporate
Communications Contact:
Deborah R. Gordon, +1 978-600-7717
Vice
President, Investor Relations and Corporate Communications
dgordon@insulet.com
or
Media
Contact:
Dominic Hulton, +44 20 3941 5374
Vice
President, Marketing, Europe
dhulton@insulet.com